News
ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission
Shares of ImmunityBio IBRX surged 17.4% after it announced a recent face-to-face meeting with senior FDA officials to align on the regulatory path forward for Anktiva in an additional indication
Notes on President Trump's Davos Speech
Wednesday, January 21st, 2026President Trump has arrived in Davos, Switzerland this morning, and presently at the podium for the annual World Economic Forum. This is, quite succinctly, the main even
Riot Platforms: A $311M AMD Deal Changes the HPC Game
In mid-January, the financial markets witnessed a notable anomaly. While Bitcoin's ($BTC) price faced significant downward pressure, dropping toward $91,000 due to rising geopolitical tensions
Can Vertiv's International Expansion Drive More Upside in the Stock?
Vertiv VRT is benefiting from strong international demand for data center infrastructure, driven by the global acceleration of digital transformation and AI adoption. The company reported a robust
Can B&G Foods' Margin Improvement Hold Amid Soft Demand?
B&G Foods, Inc.’s BGS third-quarter fiscal 2025 results reflect a difficult operating backdrop. Net sales declined 4.7% year over year to $439.3 million, while base business net sales, excluding
FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate
Eli Lilly and Company LLY announced that the FDA has granted a Breakthrough Therapy designation to its novel folate receptor alpha (FRα) antibody-drug conjugate (ADC), sofetabart mipitecan
SIFCO Plunges 14.3% in the Past Three Months: How to Play the Stock?
SIFCO Industries, Inc.'s SIF investors have been experiencing some short-term losses from the stock of late. Shares of the Cleveland, OH-based manufacturer of forgings, sub-assemblies and machined
J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales
Johnson & Johnson’s JNJ fourth-quarter 2025 earnings came in at $2.46 per share, which beat the Zacks Consensus Estimate of $2.43. Earnings rose 20.6% from the year-ago period.
Adjusted earnings
Precious Metal ETF (DBP) Hits New 52-Week High
Invesco DB Precious Metals ETF DBP is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 88.86% from its 52-week low price of $62.84 per share.
Reasons Why You Should Retain Fiserv Stock in Your Portfolio
Fiserv, Inc.’s FISV growth is fueled by the rising adoption of Software-as-a-Service (SaaS) and payment solutions by business houses. Its new acquisitions and AI innovations aid it in gaining access
Are Options Traders Betting on a Big Move in Caleres Stock?
Investors in Caleres, Inc. CAL need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 20, 2026 $30 Call had some of the highest implied
HWC Q4 Earnings Beat Estimates on Fee Income & NII, Shares Dip
Hancock Whitney Corp.’s HWC fourth-quarter 2025 earnings per share of $1.49 beat the Zacks Consensus Estimate by a penny. Further, the bottom line rose 6.4% from the prior year quarter.Results
Will Lower Active Accounts Impact Synchrony's Q4 Earnings Potential?
Consumer financial services company, Synchrony Financial SYF, is set to report fourth-quarter 2025 results on Jan. 27, before the opening bell. The Zacks Consensus Estimate for the to-be-reported
Can PANW's Secure Browser Adoption Support Long-Term SASE Growth?
Palo Alto Networks PANW is seeing strong growth in its Secured Access Service Edge (SASE) business, and secure browsers are becoming a bigger part of that story. In the first quarter of fiscal 2026
Implied Volatility Surging for Aris Mining Stock Options
Investors in Aris Mining Corporation ARMN need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $5 Call had some of the highest
NVO Expands Aspect Tie-Up to Advance Curative Diabetes Cell Therapies
Novo Nordisk NVO and Aspect Biosystems announced that they are advancing their partnership into a new phase focused on developing next-generation cellular medicines for diabetes.
The companies have
Zacks Initiates Coverage of Altigen With Neutral Recommendation
Zacks Investment Research has recently initiated coverage of Altigen Communications, Inc. ATGN with a Neutral recommendation, spotlighting both its promising strategic developments and ongoing
Reasons Why You Should Retain Docusign Stock in Your Portfolio
Docusign DOCU has a Growth Score of A, which condenses key financial metrics to reflect a fair sense of the quality and sustainability of its growth.
The company’s fourth-quarter fiscal 2026
Can HCA Q4 Earnings Withstand Higher Costs & Lower Outpatient Cases?
Hospital operator HCA Healthcare, Inc. HCA is set to report fourth-quarter 2025 results on Jan. 27, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s
Is the Options Market Predicting a Spike in European Wax Center Stock?
Investors in European Wax Center, Inc. EWCZ need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $7 Put had some of the highest
Gold ETFs Glitter Amid Renewed Transatlantic Trade Strains
January has already seen a fair share of market volatility, underscoring the year’s turbulent start and potentially setting the tone for what lies ahead in the months to come, while strengthening
Implied Volatility Surging for J.B. Hunt Transport Services Stock Options
Investors in J.B. Hunt Transport Services, Inc. JBHT need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 20, 2026 $80 Put had some of the


